Stryker reports growth in third quarter of 2013

Stryker has published its financial report for the third quarter of 2013, during which it made progress towards meeting its fiscal targets for the full year.

The medical technology firm's net sales total for the quarter came to $2.2 billion (1.36 billion pounds), up by 4.6 percent year on year, with its Reconstructive, MedSurg and Neurotechnology and Spine businesses all seeing growth.

Organic sales growth for the 2013 full-year period is projected to be in the range of 4.5 percent to 5.5 percent, with the company on track to meet its adjusted earnings per share guidance of $4.20 to $4.26.

Kevin Lobo, president and chief executive officer at Stryker, said: "We believe these results not only represent gradual improvement in our key markets but also underscore our commitment to delivering above market growth."

This comes after the company announced last month that it is to acquire Mako Surgical Corp, a specialist in the field of robotic-assisted surgery in orthopaedics.